ArticleReviews in cardiovascular medicine2025
Potential of Epicardial Adipose Tissue Quantification in Predicting Atrial Thrombus in Patients With Atrial Fibrillation.
Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epicardial adipose tissue radiomic features from pre-procedural CT to predict atrial fibrillation recurrence after catheter ablation for pulmonary vein isolation.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atrial fibrillation (AF) can increase the risk of stroke by five-fold; strokes associated with AF are more likely to lead to death or severe disability in patients. Thus, preventing the formation of thrombosis is of vital importance in the treatment of patients with AF. Epicardial adipose tissue (EAT) is a risk factor for AF and is closely associated with many AF-related complications. However, to our knowledge, no in-depth studies on the relationship between the incidence of thrombosis in AF patients and EAT have been conducted. Therefore, it is of great clinical significance to explore the potential of EAT quantification in predicting intra-atrial thrombosis in patients with AF. Methods: This is a case-control study; patients with AF who underwent coronary computed tomography angiography (CCTA) were included. These patients were divided into the thrombus group and the non-thrombus group according to the results of transesophageal echocardiography (TEE). The volume of EAT, the mean density of EAT, and the ratio of EAT volume to the whole heart volume were measured by CCTA, and the data of the two groups were compared. Meanwhile, the diagnostic efficiency of using these parameters was analyzed. Result: A total of 308 patients with AF who underwent both TEE and CCTA were enrolled in this study. After a 1:1 propensity score matching (PSM) analysis based on age and sex, a total of 76 patients were finally included. Compared with the patients in the non-thrombus group, those in the thrombus group had a larger volume of EAT (132.38 ± 45.25 cm Conclusions: The EAT volume may be a potential biomarker for predicting intra-atrial thrombosis in patients with AF; however, further validation is required to confirm the diagnostic value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.